102 related articles for article (PubMed ID: 30846937)
1. Phase I study of oral sonidegib (LDE225) in pediatric brain and solid tumors and a phase II study in children and adults with relapsed medulloblastoma.
Kieran MW; Chisholm J; Casanova M; Brandes AA; Aerts I; Bouffet E; Bailey S; Leary S; MacDonald TJ; Mechinaud F; Cohen KJ; Riccardi R; Mason W; Hargrave D; Kalambakas S; Deshpande P; Tai F; Hurh E; Geoerger B
Neuro Oncol; 2017 Oct; 19(11):1542-1552. PubMed ID: 28605510
[TBL] [Abstract][Full Text] [Related]
2. Hedgehog signaling pathway and its targets for treatment in basal cell carcinoma.
Cucchi D; Occhione MA; Gulino A; De Smaele E
J Exp Pharmacol; 2012; 4():173-85. PubMed ID: 27186130
[TBL] [Abstract][Full Text] [Related]
3. Drug Delivery Systems for Hedgehog Inhibitors in the Treatment of SHH-Medulloblastoma.
Caimano M; Lospinoso Severini L; Loricchio E; Infante P; Di Marcotullio L
Front Chem; 2021; 9():688108. PubMed ID: 34164380
[TBL] [Abstract][Full Text] [Related]
4. Targeting Super-Enhancer-Driven Transcriptional Dependencies Suppresses Aberrant Hedgehog Pathway Activation and Overcomes Smoothened Inhibitor Resistance.
Sui Y; Wang T; Mei Y; Zhu Y; Jiang W; Shen J; Yan S; Lu W; Zhao K; Mo J; Wang C; Tang Y
Cancer Res; 2024 May; ():. PubMed ID: 38775809
[TBL] [Abstract][Full Text] [Related]
5. Molecular docking approaches in identification of High affinity inhibitors of Human SMO receptor.
Akare UR; Bandaru S; Shaheen U; Singh PK; Tiwari G; Singare P; Nayarisseri A; Banerjee T
Bioinformation; 2014; 10(12):737-42. PubMed ID: 25670876
[TBL] [Abstract][Full Text] [Related]
6. NEK2 promotes proliferation, migration and tumor growth of gastric cancer cells via regulating KDM5B/H3K4me3.
Li Y; Chen L; Feng L; Zhu M; Shen Q; Fang Y; Liu X; Zhang X
Am J Cancer Res; 2019; 9(11):2364-2378. PubMed ID: 31815040
[TBL] [Abstract][Full Text] [Related]
7. Molecular Mechanisms Involving the Sonic Hedgehog Pathway in Lung Cancer Therapy: Recent Advances.
Ma C; Hu K; Ullah I; Zheng QK; Zhang N; Sun ZG
Front Oncol; 2022; 12():729088. PubMed ID: 35433472
[TBL] [Abstract][Full Text] [Related]
8. An early foray with targeted therapy and inspiring novel approaches to combat adult medulloblastoma.
Shih HA
Neuro Oncol; 2021 Nov; 23(11):1814-1815. PubMed ID: 34270765
[No Abstract] [Full Text] [Related]
9. Identification of a potent antagonist of smoothened in hedgehog signaling.
Fan J; Li H; Kuang L; Zhao Z; He W; Liu C; Wang Y; Cheng SY; Chen W
Cell Biosci; 2021 Mar; 11(1):46. PubMed ID: 33653381
[TBL] [Abstract][Full Text] [Related]
10. Medulloblastoma drugs in development: Current leads, trials and drawbacks.
Wen J; Hadden MK
Eur J Med Chem; 2021 Apr; 215():113268. PubMed ID: 33636537
[TBL] [Abstract][Full Text] [Related]
11. NL-103, a novel dual-targeted inhibitor of histone deacetylases and hedgehog pathway, effectively overcomes vismodegib resistance conferred by Smo mutations.
Zhao J; Quan H; Xie C; Lou L
Pharmacol Res Perspect; 2014 Jun; 2(3):e00043. PubMed ID: 25505589
[TBL] [Abstract][Full Text] [Related]
12. Sonidegib: mechanism of action, pharmacology, and clinical utility for advanced basal cell carcinomas.
Jain S; Song R; Xie J
Onco Targets Ther; 2017; 10():1645-1653. PubMed ID: 28352196
[TBL] [Abstract][Full Text] [Related]
13. Strategies to target the Hedgehog signaling pathway for cancer therapy.
Xin M; Ji X; De La Cruz LK; Thareja S; Wang B
Med Res Rev; 2018 May; 38(3):870-913. PubMed ID: 29315702
[TBL] [Abstract][Full Text] [Related]
14. L-4, a Well-Tolerated and Orally Active Inhibitor of Hedgehog Pathway, Exhibited Potent Anti-tumor Effects Against Medulloblastoma
Zhu M; Wang H; Wang C; Fang Y; Zhu T; Zhao W; Dong X; Zhang X
Front Pharmacol; 2019; 10():89. PubMed ID: 30846937
[TBL] [Abstract][Full Text] [Related]
15. Novel-smoothened inhibitors for therapeutic targeting of naïve and drug-resistant hedgehog pathway-driven cancers.
Li QR; Zhao H; Zhang XS; Lang H; Yu K
Acta Pharmacol Sin; 2019 Feb; 40(2):257-267. PubMed ID: 29777201
[TBL] [Abstract][Full Text] [Related]
16. Phase I and phase II sonidegib and vismodegib clinical trials for the treatment of paediatric and adult MB patients: a systemic review and meta-analysis.
Li Y; Song Q; Day BW
Acta Neuropathol Commun; 2019 Jul; 7(1):123. PubMed ID: 31362788
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
